🟢 Indaptus Therapeutics is trading 9.72% up in after-hours trading with no identified catalyst

Indaptus Therapeutics is trading at $3.61, up 9.72% versus the regular-session close of $3.29; the cause of the after-hours rise is unclear.

• No new company-specific catalyst was identified for September 28; the reported private placement was not new, and the regular-session decline came amid broader-market weakness.
• Reuters reported oil prices and Treasury yields rose after the U.S. rejected Iran’s proposal, weighing on stocks; that market decline does not explain the after-hours rise.